FDA

Haryana Suspends 966 Drug Sale Licences After Inspections, Cancels 15 More Over Irregularities

Haryana Suspends 966 Drug Sale Licences After Inspections, Cancels 15 More Over Irregularities

Chandigarh (Balwinder Singh): The Haryana government has suspended 966 drug sale licences and 12 manufacturing or blood centre licences following inspections carried out between April 1 and September 30, 2026. During the same period, 15 licences were cancelled completely and five were partially cancelled over alleged violations and irregularities. Health Minister Aarti Singh Rao said the state government was committed to ensuring that residents had access to safe and quality medicines. She added that the Food and Drug Administration (FDA) had been directed to take strict action against those involved in manufacturing or selling counterfeit drugs. According to an FDA…
Read More
Haryana Cracks Down on Counterfeit Drug Syndicates: 16 Arrested, Major Seizures Reported

Haryana Cracks Down on Counterfeit Drug Syndicates: 16 Arrested, Major Seizures Reported

Chandigarh (Balwinder Singh): Haryana has emerged as a leader in the nationwide fight against the illicit pharmaceutical trade, with the Food and Drug Administration (FDA) executing a series of high-profile crackdowns under the Drugs and Cosmetics Act, 1940. State authorities have arrested 16 individuals for their involvement in the manufacturing and distribution of spurious medicines. Of these, 12 arrests were secured by the FDA Gurugram unit, which has successfully dismantled several interstate smuggling networks and confiscated counterfeit medications valued at approximately ₹70 lakh. The enforcement drive is being executed under the directives of Dr. Sumita Misra, Additional Chief Secretary of…
Read More